Tandem Diabetes Care, Inc. TNDM announced that the in-warranty users of the t:slim X2 insulin pump in Canada can now access full compatibility with both Dexcom’s DXCM G7 and G6 Continuous Glucose ...

DexCom, Inc. DXCM recently announced the FDA clearance for its 15-day wear G7 Continuous Glucose Monitoring (CGM) system, the ...

The US Food and Drug Administration has cleared the Dexcom ... G7 15-day will also connect to your Apple Watch to monitor your glucose levels without having your phone close. The impact isn't ...

Now the longest lasting and most accurate CGM system, Dexcom G7 15 Day gives users the knowledge to better control diabetes. Dexcom G7 15 Day builds on the performance of Dexcom CGM, which is ...

"We conclude that the Dexcom 15-day G7 CGM is accurate and safe for use up to 15.5 days in adults with diabetes with a 27-minute warm-up," stated the investigators.

Dexcom G7 15 Day is expected to launch in the U.S. in the second half of 2025. Price Action: DXCM stock is up 0.22% at $66.99 at the last check on Thursday. Read Next: ...

DexCom, Inc. DXCM recently announced the ... to Insulet Corporation’s Omnipod and Tandem Diabetes Care’s t:slim X2. ???In March, DXCM signed a licensing and data partnership with Nanowear ...

announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the United States. With an overall MARD of 8.0% ...

Now the longest lasting and most accurate CGM system, Dexcom G7 15 Day gives users the knowledge to better control diabetes. Dexcom G7 15 Day builds on the performance of Dexcom CGM, which is ...